Long-term efficacy of a new 6-session cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder : A randomized, controlled clinical trial

Copyright © 2023. Published by Elsevier B.V..

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects about 2.8 % of the adult population. Cognitive behavioral therapy (CBT) has been demonstrated to be the most effective psychological intervention for ADHD. The aim of this study was to explore the efficacy of a new 6-session CBT program in comparison with a 12-session CBT program for adults with ADHD at short- and long-term.

METHODS: 81 adults with ADHD (58 % males; mean age = 41.27±9.26 years old) were randomly assigned to each treatment condition (6- or 12-session CBT). Validated instruments were used to assess ADHD symptoms, comorbidities (anxiety and depression), and functional impairments at post treatment, and at 3- and 6-month follow-up.

RESULTS: A significant improvement in ADHD severity, comorbidities (anxiety and depression) and functional impairments were found in both CBT programs after treatment. Furthermore, this improvement was also reported at 3- and 6-month follow-up.

CONCLUSION: The current study highlights that a 6-session CBT program is as effective as a 12-session CBT program for ADHD improvement at post treatment and follow-up. The newly developed 6-session CBT program can be used to treat a larger number of patients, reducing the financial cost.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:331

Enthalten in:

Psychiatry research - 331(2024) vom: 26. Jan., Seite 115642

Sprache:

Englisch

Beteiligte Personen:

Corrales, M [VerfasserIn]
García-González, S [VerfasserIn]
Richarte, V [VerfasserIn]
Fadeuilhe, C [VerfasserIn]
Daigre, C [VerfasserIn]
García-Gea, E [VerfasserIn]
Ramos-Quiroga, J A [VerfasserIn]

Links:

Volltext

Themen:

ADHD
Adult ADHD
CBT
Cognitive behavioral therapy
Journal Article
Randomized Controlled Trial

Anmerkungen:

Date Completed 02.01.2024

Date Revised 02.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.psychres.2023.115642

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365939765